Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05460416 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer

Study acronym: TePPAFET
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 18, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv4
  2. Phase: Phase 4 to Phase 3v3 Show 6 more changesShow less
    • Lead sponsor: Centre Hospitalier Régional de la Citadelle to Centre Hospitalier Universitaire de Liege
    • Enrollment target: 3000 to 276
    • Start date: Aug 22, 2022 to Oct 25, 2022
    • Study completion date: Dec 31, 2025 to Jun 30, 2026
    • Study site revised
    • Study description expanded, about 1 word
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Title: A prospective multicentric interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of pre-eclampsia in pregnant women who underwent frozen embryo transfer
Trial Details
NCT Number NCT05460416
Lead Sponsor Centre Hospitalier Universitaire de Liege
Conditions
(from sponsor)		 Embryo Transfer, Hypertension, Pregnancy Induced
Related terms Hypertension, Pregnancy-Induced
Enrollment 276 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov